Lactam-bridged melanocortin receptor-specific peptides

作者: Wei Yang , Xin Chen

DOI:

关键词:

摘要: Lactam-bridged melanocortin receptor-specific cyclic peptides of the formula (I) where R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in specification, compositions formulations including peptide foregoing formula, methods preventing, ameliorating or treating receptor-mediated diseases, indications, conditions syndromes, obesity, modulation feeding behavior, related metabolic syndrome, sexual dysfunction, male erectile dysfunction female dysfunction.

参考文章(66)
Ilze Mutule, Felikss Mutulis, Ruta Muceniece, Jarl Wikberg, Helgi Schioeth, Compounds for control of eating, growth and body weight ,(1999)
Leif Christensen, Ulrich Sensfuss, Peptides for use in the treatment of obesity ,(2008)
Heather A. Halem, Michael Dewitt Culler, Andrew A. Butler, Use of melanocortins to treat insulin sensitivity ,(2008)
Sejin Lim, Wei Yuan, Victor J. Huby, Melanocortin receptor antagonists and agonists ,(1997)
Kirsten Raun, Birgit Sehested Hansen, Birgitte Schjellerup Wulff, Use of peptides in combination with surgical intervention for the treatment of obesity ,(2008)
D Giuliani, C Mioni, C Bazzani, D Zaffe, A R Botticelli, S Capolongo, A Sabba, M Galantucci, A Iannone, P Grieco, E Novellino, G Colombo, A Tomasi, A Catania, S Guarini, Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. British Journal of Pharmacology. ,vol. 150, pp. 595- 603 ,(2007) , 10.1038/SJ.BJP.0707115